Dopamine dynamics may be dispensable for movement but promote reward responses

A study in mice shows that rapid dopamine release in the brain is not necessary for initiating movement, but it plays a key role in motivation and reward-seeking behaviors. If these results apply to humans, they may help explain why the Parkinson's treatment levodopa (L-DOPA) improves motor symptoms but doesn't fully address nonmotor issues like cognitive difficulties. Dr. Pascal Kaeser from Harvard Medical School, who led the study, suggests this could lead to new therapies targeting faster and more precise dopamine signaling to improve cognitive symptoms in Parkinson's disease. The research was published in Nature. Dopamine is a neurotransmitter essential for motor control, learning, and cognitive tasks. While it was long thought that movement relied on a rapid release of dopamine, this study found that genetically modified mice lacking the ability for fast dopamine release could still initiate movement. However, when dopamine was depleted, starting movement became more difficult, indicating some dopamine is necessary. Interestingly, these mice showed reduced motivation in reward-related tasks, indicating that fast dopamine action is critical for cognitive functions like motivation and reward-seeking. Although levodopa restored motor control in mice with depleted dopamine, it did not reestablish the fast dopamine dynamics needed for motivation, possibly explaining why levodopa is less effective for nonmotor symptoms in Parkinson's patients.